Akoya Biosciences CEO Brian McKelligon's 2023 pay slips 4% to $2.9M
Akoya Biosciences reports 2023 executive compensation
By ExecPay News
Published: April 23, 2024
Akoya Biosciences reported fiscal year 2023 executive compensation information on April 23, 2024.
In 2023, three executives at Akoya Biosciences received on average a compensation package of $2.1M, a 18% increase compared to previous year.
Average pay of disclosed executives at Akoya Biosciences
Brian McKelligon, Chief Executive Officer, received $2.9M in total, which decreased by 4% compared to 2022. 37% of McKelligon's compensation, or $1.1M, was in option awards. McKelligon also received $307K in non-equity incentive plan, $543K in salary, $984K in stock awards, as well as $5.4K in other compensation.
Johnny Ek, Chief Financial Officer, received a compensation package of $2.3M. 53% of the compensation package, or $1.2M, was in stock awards.
Frederic Pla, Chief Operating Officer, earned $1.2M in 2023.
Related executives
You may also like
Source: SEC filing on April 23, 2024.